Skip to main content
PMC home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1992 Feb;51(2):220–226. doi: 10.1136/ard.51.2.220

Differential metabolism of 25-hydroxyvitamin D3 by cultured synovial fluid macrophages and fibroblast-like cells from patients with arthritis.

M E Hayes 1, D Bayley 1, P Still 1, J Palit 1, J Denton 1, A J Freemont 1, R G Cooper 1, E B Mawer 1
PMCID: PMC1005662  PMID: 1550407

Abstract

Differential metabolism of 25-hydroxyvitamin D3 (25(OH)D3) has been shown for macrophages and fibroblast-like cells (possibly synoviocytes) cultured for two to 50 days after isolation from the synovial fluid of 12 patients with various forms of inflammatory arthritis. Macrophages synthesised the active metabolite of vitamin D3, 1,25-dihydroxyvitamin D3 (1,25(OH)2D3), the synthesis of which was increased by bacterial lipopolysaccharide, a known macrophage activating factor. In contrast, fibroblast-like cells formed 24, 25-dihydroxyvitamin D3 (24,25(OH)2D3), synthesis of which was stimulated by 1,25(OH)2D3 and inhibited by lipopolysaccharide. The synthesis of 1,25(OH)2D3 and 24,25(OH)2D3 by macrophages and fibroblast-like cells respectively was inhibited by ketoconazole, indicating that both hydroxylases are dependent on cytochrome P-450. Mean (SEM) synovial fluid and serum 25(OH)D3 concentrations were 16.7 (1.7) and 22.2 (2.6) ng/ml and those of 1,25(OH)2D3 were 29.4 (4.8) and 43.3 (4.0) pg/ml respectively. In most cases concentrations were lower in synovial fluid than in paired serum samples, but in two patients 1,25(OH)2D3 concentrations were greater in synovial fluid than in serum, suggesting local synthesis within the affected joints.

Full text

PDF
221

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abe E., Miyaura C., Tanaka H., Shiina Y., Kuribayashi T., Suda S., Nishii Y., DeLuca H. F., Suda T. 1 alpha,25-dihydroxyvitamin D3 promotes fusion of mouse alveolar macrophages both by a direct mechanism and by a spleen cell-mediated indirect mechanism. Proc Natl Acad Sci U S A. 1983 Sep;80(18):5583–5587. doi: 10.1073/pnas.80.18.5583. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Adams J. S., Sharma O. P., Gacad M. A., Singer F. R. Metabolism of 25-hydroxyvitamin D3 by cultured pulmonary alveolar macrophages in sarcoidosis. J Clin Invest. 1983 Nov;72(5):1856–1860. doi: 10.1172/JCI111147. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bar-Shavit Z., Teitelbaum S. L., Reitsma P., Hall A., Pegg L. E., Trial J., Kahn A. J. Induction of monocytic differentiation and bone resorption by 1,25-dihydroxyvitamin D3. Proc Natl Acad Sci U S A. 1983 Oct;80(19):5907–5911. doi: 10.1073/pnas.80.19.5907. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Barsony J., McKoy W., DeGrange D. A., Liberman U. A., Marx S. J. Selective expression of a normal action of the 1,25-dihydroxyvitamin D3 receptor in human skin fibroblasts with hereditary severe defects in multiple actions of that receptor. J Clin Invest. 1989 Jun;83(6):2093–2101. doi: 10.1172/JCI114122. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bhalla A. K., Amento E. P., Clemens T. L., Holick M. F., Krane S. M. Specific high-affinity receptors for 1,25-dihydroxyvitamin D3 in human peripheral blood mononuclear cells: presence in monocytes and induction in T lymphocytes following activation. J Clin Endocrinol Metab. 1983 Dec;57(6):1308–1310. doi: 10.1210/jcem-57-6-1308. [DOI] [PubMed] [Google Scholar]
  6. Bird H. A., Wright V., Hennes U., Theiss E. Comparison of serum 1,25-dihydroxycholecalciferol concentrations in rheumatoid arthritis and osteoarthrosis. Ann Rheum Dis. 1982 Jun;41(3):257–258. doi: 10.1136/ard.41.3.257. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Cancela L., Rebut-Bonneton C. Regulation of 24-hydroxylase activity in mouse skin fibroblast by cholecalciferol derivatives, triamcinolone acetonide and a calcium modulating agent, nicardipine. J Steroid Biochem. 1987 Nov;28(5):479–484. doi: 10.1016/0022-4731(87)90505-x. [DOI] [PubMed] [Google Scholar]
  8. Davies M., Mawer E. B., Hayes M. E., Lumb G. A. Abnormal vitamin D metabolism in Hodgkin's lymphoma. Lancet. 1985 May 25;1(8439):1186–1188. doi: 10.1016/s0140-6736(85)92864-8. [DOI] [PubMed] [Google Scholar]
  9. Fairney A., Straffen A. M., May C., Seifert M. H. Vitamin D metabolites in synovial fluid. Ann Rheum Dis. 1987 May;46(5):370–374. doi: 10.1136/ard.46.5.370. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Freemont A. J., Davies J. S. Acid esterase activity in lymphocytes and other cells: a comparison of six alpha-naphthyl based substrates. Med Lab Sci. 1982 Oct;39(4):405–407. [PubMed] [Google Scholar]
  11. Gamblin G. T., Liberman U. A., Eil C., Downs R. W., Jr, DeGrange D. A., Marx S. J. Vitamin D-dependent rickets type II. Defective induction of 25-hydroxyvitamin D3-24-hydroxylase by 1,25-dihydroxyvitamin D3 in cultured skin fibroblasts. J Clin Invest. 1985 Mar;75(3):954–960. doi: 10.1172/JCI111796. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Garabedian M., Lieberherr M., N'Guyen T. M., Corvol M. T., Du Bois M. B., Balsan S. The in vitro production and activity of 24, 25-dihydroxycholecalciferol in cartilage and calvarium. Clin Orthop Relat Res. 1978 Sep;(135):241–248. [PubMed] [Google Scholar]
  13. Haussler M. R., McCain T. A. Basic and clinical concepts related to vitamin D metabolism and action (first of two parts). N Engl J Med. 1977 Nov 3;297(18):974–983. doi: 10.1056/NEJM197711032971804. [DOI] [PubMed] [Google Scholar]
  14. Hayes M. E., Denton J., Freemont A. J., Mawer E. B. Synthesis of the active metabolite of vitamin D, 1,25(OH)2D3, by synovial fluid macrophages in arthritic diseases. Ann Rheum Dis. 1989 Sep;48(9):723–729. doi: 10.1136/ard.48.9.723. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Hayes M. E., O'Donoghue D. J., Ballardie F. W., Mawer E. B. Peritonitis induces the synthesis of 1 alpha,25-dihydroxyvitamin D3 in macrophages from CAPD patients. FEBS Lett. 1987 Aug 17;220(2):307–310. doi: 10.1016/0014-5793(87)80836-0. [DOI] [PubMed] [Google Scholar]
  16. Henry H. L. Effect of ketoconazole and miconazole on 25-hydroxyvitamin D3 metabolism by cultured chick kidney cells. J Steroid Biochem. 1985 Dec;23(6A):991–994. doi: 10.1016/0022-4731(85)90057-3. [DOI] [PubMed] [Google Scholar]
  17. Koeffler H. P., Reichel H., Bishop J. E., Norman A. W. gamma-Interferon stimulates production of 1,25-dihydroxyvitamin D3 by normal human macrophages. Biochem Biophys Res Commun. 1985 Mar 15;127(2):596–603. doi: 10.1016/s0006-291x(85)80202-3. [DOI] [PubMed] [Google Scholar]
  18. Loose D. S., Kan P. B., Hirst M. A., Marcus R. A., Feldman D. Ketoconazole blocks adrenal steroidogenesis by inhibiting cytochrome P450-dependent enzymes. J Clin Invest. 1983 May;71(5):1495–1499. doi: 10.1172/JCI110903. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Manolagas S. C., Werntz D. A., Tsoukas C. D., Provvedini D. M., Vaughan J. H. 1,25-Dihydroxyvitamin D3 receptors in lymphocytes from patients with rheumatoid arthritis. J Lab Clin Med. 1986 Dec;108(6):596–600. [PubMed] [Google Scholar]
  20. Mawer E. B., Hann J. T., Berry J. L., Davies M. Vitamin D metabolism in patients intoxicated with ergocalciferol. Clin Sci (Lond) 1985 Feb;68(2):135–141. doi: 10.1042/cs0680135. [DOI] [PubMed] [Google Scholar]
  21. Narbaitz R., Stumpf W. E., Sar M., Huang S., DeLuca H. F. Autoradiographic localization of target cells for 1 alpha, 25-dihydroxyvitamin D3 in bones from fetal rats. Calcif Tissue Int. 1983;35(2):177–182. doi: 10.1007/BF02405028. [DOI] [PubMed] [Google Scholar]
  22. Provvedini D. M., Tsoukas C. D., Deftos L. J., Manolagas S. C. 1,25-dihydroxyvitamin D3 receptors in human leukocytes. Science. 1983 Sep 16;221(4616):1181–1183. doi: 10.1126/science.6310748. [DOI] [PubMed] [Google Scholar]
  23. Pryke A. M., Duggan C., White C. P., Posen S., Mason R. S. Tumor necrosis factor-alpha induces vitamin D-1-hydroxylase activity in normal human alveolar macrophages. J Cell Physiol. 1990 Mar;142(3):652–656. doi: 10.1002/jcp.1041420327. [DOI] [PubMed] [Google Scholar]
  24. Raisz L. G., Kream B. E., Smith M. D., Simmons H. A. Comparison of the effects of vitamin D metabolites on collagen synthesis and resportion of fetal rat bone in organ culture. Calcif Tissue Int. 1980;32(2):135–138. doi: 10.1007/BF02408532. [DOI] [PubMed] [Google Scholar]
  25. Reichel H., Koeffler H. P., Bishop J. E., Norman A. W. 25-Hydroxyvitamin D3 metabolism by lipopolysaccharide-stimulated normal human macrophages. J Clin Endocrinol Metab. 1987 Jan;64(1):1–9. doi: 10.1210/jcem-64-1-1. [DOI] [PubMed] [Google Scholar]
  26. Reichel H., Koeffler H. P., Norman A. W. Synthesis in vitro of 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 by interferon-gamma-stimulated normal human bone marrow and alveolar macrophages. J Biol Chem. 1987 Aug 15;262(23):10931–10937. [PubMed] [Google Scholar]
  27. Reichel H., Koeffler H. P., Norman A. W. The role of the vitamin D endocrine system in health and disease. N Engl J Med. 1989 Apr 13;320(15):980–991. doi: 10.1056/NEJM198904133201506. [DOI] [PubMed] [Google Scholar]
  28. Sambrook P. N., Reeve J. Bone disease in rheumatoid arthritis. Clin Sci (Lond) 1988 Mar;74(3):225–230. doi: 10.1042/cs0740225. [DOI] [PubMed] [Google Scholar]
  29. Sambrook P. N., Shawe D., Hesp R., Zanelli J. M., Mitchell R., Katz D., Gumpel J. M., Ansell B. M., Reeve J. Rapid periarticular bone loss in rheumatoid arthritis. Possible promotion by normal circulating concentrations of parathyroid hormone or calcitriol (1,25-dihydroxyvitamin D3). Arthritis Rheum. 1990 May;33(5):615–622. doi: 10.1002/art.1780330503. [DOI] [PubMed] [Google Scholar]
  30. Sandler L. M., Winearls C. G., Fraher L. J., Clemens T. L., Smith R., O'Riordan J. L. Studies of the hypercalcaemia of sarcoidosis: effect of steroids and exogenous vitamin D3 on the circulating concentrations of 1,25-dihydroxy vitamin D3. Q J Med. 1984 Spring;53(210):165–180. [PubMed] [Google Scholar]
  31. Shiozawa S., Shiozawa K., Tanaka Y., Fujita T. 1 alpha,25-Dihydroxyvitamin D3 inhibits proliferative response of T- and B-lymphocytes in a serum-free culture. Int J Immunopharmacol. 1987;9(6):719–723. doi: 10.1016/0192-0561(87)90043-9. [DOI] [PubMed] [Google Scholar]
  32. Tsoukas C. D., Provvedini D. M., Manolagas S. C. 1,25-dihydroxyvitamin D3: a novel immunoregulatory hormone. Science. 1984 Jun 29;224(4656):1438–1440. doi: 10.1126/science.6427926. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES